The objectives of the STREXIT 2 Project in the words of Principal Investigator and Co-Leader Dr Winan van Houdt
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part of the EU Mission on Cancer. The twelve clinical trials, led by multistakeholder and multidisciplinary consortiums, form together the European Cancer Cluster.
Celebrating Sarcoma Awareness Month with the start of EU-funded STREXIT2 project study
On Sarcoma Awareness Month, the European Organisation for Research and Treatment of Cancer (EORTC) and the Syreon Research Institute are delighted to announce the official start of STREXIT2, a complementary observational study of the EORTC 1809 STRASS2 clinical trial focusing on high-risk retroperitoneal sarcoma. STREXIT2 is one of three research projects coordinated by the EORTC, alongside DE-ESCALATE and LEGATO, […]
